Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor
- PMID: 7673254
- DOI: 10.1074/jbc.270.38.22639
Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor
Abstract
The wild type insulin-like growth factor I (IGF-I) receptor has both mitogenic and transforming activities. We have examined the effect of point mutations at tyrosine residues 1250 and 1251 on these two properties of the receptor. For this purpose, we stably transfected plasmids expressing mutant and wild type receptors into R- cells, which are 3T3-like cells, derived from mouse embryos with a targeted disruption of the IGF-I receptor genes, and therefore devoid of endogenous IGF-I receptors. A tyrosine to phenylalanine mutation of either the 1250 or 1251 residue, or both, has no effect on the ability of the receptor to transmit a mitogenic signal. However, the tyrosine 1251 mutant receptor and the double mutant have lost the ability to transform R- cells (colony formation in soft agar), even when the receptors are expressed at very high levels, while the Y1250F mutant is fully transforming. These experiments show that the 1251 tyrosine residue is required for the transforming activity of the IGF-I receptor.
Similar articles
-
Insulin-like growth factor I receptor signaling in transformation by src oncogenes.Mol Cell Biol. 1997 Jul;17(7):3744-54. doi: 10.1128/MCB.17.7.3744. Mol Cell Biol. 1997. PMID: 9199308 Free PMC article.
-
Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.Endocrinology. 1997 Jul;138(7):2979-88. doi: 10.1210/endo.138.7.5281. Endocrinology. 1997. PMID: 9202243
-
The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.Mol Endocrinol. 2000 Jun;14(6):805-13. doi: 10.1210/mend.14.6.0487. Mol Endocrinol. 2000. PMID: 10847583
-
Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.J Biol Chem. 2004 Apr 30;279(18):18306-13. doi: 10.1074/jbc.M309234200. Epub 2004 Feb 12. J Biol Chem. 2004. PMID: 14963047
-
Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.Cancer Res. 1995 Feb 1;55(3):663-7. Cancer Res. 1995. PMID: 7834637
Cited by
-
Insulin-like growth factor II stimulates cell proliferation through the insulin receptor.Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3777-82. doi: 10.1073/pnas.94.8.3777. Proc Natl Acad Sci U S A. 1997. PMID: 9108054 Free PMC article.
-
Insulin Receptor Isoforms in Physiology and Disease: An Updated View.Endocr Rev. 2017 Oct 1;38(5):379-431. doi: 10.1210/er.2017-00073. Endocr Rev. 2017. PMID: 28973479 Free PMC article. Review.
-
Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.J Biol Chem. 2012 Mar 30;287(14):11422-36. doi: 10.1074/jbc.M111.252478. Epub 2012 Feb 8. J Biol Chem. 2012. PMID: 22318726 Free PMC article.
-
Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance.Int J Mol Sci. 2023 Oct 9;24(19):15006. doi: 10.3390/ijms241915006. Int J Mol Sci. 2023. PMID: 37834454 Free PMC article. Review.
-
IGF and insulin receptor signaling in breast cancer.J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):381-406. doi: 10.1007/s10911-008-9099-z. Epub 2008 Nov 19. J Mammary Gland Biol Neoplasia. 2008. PMID: 19016312
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
